DMBA induces an A>T stereotypic mutational signature, and similar to human cSCCs, these cancers are characterized by recurrent mutations in Hras and, to a lesser extent, Kras and Rras2 (Bizub et al. 1986; Quintanilla et al. 1986; Nassar et al. 2015). Here, HRAS is linked to cancer.